MPO and idiopathic pulmonary fibrosis: Currently, the ATS/ERS/JRS/ALAT guidelines for the diagnosis of IPF suggest that ANCA testing be considered only when systemic vasculitis is suspected on clinical grounds8; however, others have argued that detection of MPO‐ANCA antibodies through routine assessment at IPF/UIP diagnosis might enable early recognition.6, 9